company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17268000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10114000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27382000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27327000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1058000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-185000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,873000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26454000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26454000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26454000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26454000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17038000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.55
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17038000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.55
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 16:39:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.55
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3021000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3021000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,128000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,128000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2893000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19351000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6109000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25460000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22567000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,503000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,505000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22062000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22062000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22062000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22062000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17117000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.29
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17117000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.29
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:17:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.29
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13306000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13306000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1010000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1010000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12296000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23456000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12368000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35824000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23528000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,471000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,475000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23053000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23053000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23053000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23053000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19985000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19985000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20000000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 10:51:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18827000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18827000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1884000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1884000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16943000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24004000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14784000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38788000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21845000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1198000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-788000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,410000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21435000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-111000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21324000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21324000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21324000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21017000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21017000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 16:39:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16892000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16892000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2274000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2274000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14618000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17986000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14031000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32017000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17399000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,448000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-396000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17347000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-351000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16996000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16996000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16996000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21085000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21085000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17220000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17220000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2438000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2438000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14782000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19493000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13279000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2224000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34996000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20214000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-376000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,424000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19790000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19780000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19780000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19780000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.74
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.74
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20806000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.74
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13385000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13385000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3041000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3041000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10344000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19634000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13566000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22856000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,560000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,561000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21144000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 13:05:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21144000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15402000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15402000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2082000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2082000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13320000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16826000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16695000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33521000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20201000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,452000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-209000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,243000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19958000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-396000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19562000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19562000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19562000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21167000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21167000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21167000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 11:18:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17555000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17555000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2669000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2669000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14886000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17230000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14894000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32124000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,378000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,392000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16846000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-215000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16631000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16631000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16631000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21194000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21194000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 17:22:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21194000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14907000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14907000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2739000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2739000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12168000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15173000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12985000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3508000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31666000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19498000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,357000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,358000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19140000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-559000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18581000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18581000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18581000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21189000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21189000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21189000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15480000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15480000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2646000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2646000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12834000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13181000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12462000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25643000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12809000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,393000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,393000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12416000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12416000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12416000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12416000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21349000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21349000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:47:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21349000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31012000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31012000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3224000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3224000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27788000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15101000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7671000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1058000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23830000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3958000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,338000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1471000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1133000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2825000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-494000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3319000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3319000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3319000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21370000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21649000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21370000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:07:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17742000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17742000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4323000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4323000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13419000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12160000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5260000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,562000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17982000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4563000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,297000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4266000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-299000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3967000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3967000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3967000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21403000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21403000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 16:06:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21403000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21144000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21144000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4027000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4027000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17117000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12629000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7903000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,595000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21127000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4010000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,260000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,263000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3747000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-61000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3686000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3686000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3686000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21392000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.94
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21392000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.93
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21392000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.94
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17880000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17880000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2942000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2942000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14938000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14005000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5404000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19409000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4471000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,271000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,305000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,576000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3895000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3895000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3895000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3895000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21544000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21544000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 08:01:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21544000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19649000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19649000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16504000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15211000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4049000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19260000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2756000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,256000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,592000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,848000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1908000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1908000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1908000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1908000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21603000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21603000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:31:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21603000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21616000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21616000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19069000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14934000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4530000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19464000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-395000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,246000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,250000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21691000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21691000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:01:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21711000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21711000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3326000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3326000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18385000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15017000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6581000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,782000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22380000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3995000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,278000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,63000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,341000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3654000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3654000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3654000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3654000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21703000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21703000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21703000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20835000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20835000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2837000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2837000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17998000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17491000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6498000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23989000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5991000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1476000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,265000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1111000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7102000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7102000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7102000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7102000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21824000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21824000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:14:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24802000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24802000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2743000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2743000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22059000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16284000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4540000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20824000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1235000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3051000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,253000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2782000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1547000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21925000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21925000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q2,2014-04-01,2014-06-30,2015-07-27 06:06:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25494000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25494000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2968000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2968000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22526000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10958000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5358000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1917000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18233000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4293000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3129000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,291000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2835000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1458000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1458000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1458000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1458000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21984000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23467000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:01:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53253000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53253000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11758000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11758000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41495000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27521000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7764000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9584000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44869000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3374000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7041000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,166000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,98000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6777000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10151000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-153159000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143008000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143008000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143008000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22416000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.39
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25225000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.79
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22400000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.39
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89505000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89505000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21026000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21026000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,68479000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32112000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6988000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,571000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39671000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28808000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10367000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10296000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18512000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5608000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12904000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12904000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12904000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27213000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38245000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 09:20:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,123884000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,123884000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19679000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19679000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104205000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31801000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8184000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3096000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43081000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61124000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10205000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,372000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9831000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51293000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18035000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33258000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33258000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33258000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30636000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43181000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96152000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96152000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22349000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22349000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73803000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46141000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19809000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75188000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1385000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24671000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,524000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9182000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33329000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34714000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14130000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20584000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20584000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20584000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33223000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33223000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:42:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,108735000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,108735000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25447000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25447000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83288000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50255000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7897000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2463000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60615000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22673000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18457000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,545000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17920000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4753000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2448000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7201000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7201000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7201000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31471000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35308000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,109300000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,109300000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23826000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23826000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85474000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63175000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14229000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,622000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78026000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7448000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18443000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,708000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,220000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17515000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10067000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2540000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7527000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7527000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7527000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34739000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34739000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 08:11:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,127419000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,127419000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27132000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27132000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100287000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51924000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14234000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15963000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,89000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82210000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18077000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18250000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,773000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17477000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,600000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1196000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-596000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-596000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-596000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34223000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34223000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:04:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143782000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143782000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30690000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30690000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113092000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57216000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17116000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74332000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38760000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18309000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,838000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17495000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21265000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5069000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16196000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16196000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16196000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34171000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42111000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 17:42:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,139448000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,139472000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32583000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32583000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106889000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70424000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,76489000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146913000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40024000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18300000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1058000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17242000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57266000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-20706000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36560000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36560000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36560000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34378000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34378000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:12:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,130371000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,130371000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32101000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32101000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98270000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58900000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36103000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95003000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3267000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26772000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,663000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-69000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26178000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22911000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8659000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14252000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,186000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14066000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14066000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35145000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 09:12:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124331000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124331000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31085000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31085000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93246000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11962000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16274000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,319246000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,347482000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-254236000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17161000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,487000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16674000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-270910000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-115197000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-155713000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3652000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-152061000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-152061000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.31
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.31
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35311000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:32:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.31
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,101619000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-24000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,101595000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,65580000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,65580000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36015000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36865000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11996000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48861000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12846000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17075000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,602000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16474000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29320000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30692000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1372000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2087000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3459000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3459000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34907000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34907000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34907000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117387000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117387000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,63912000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,63912000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53475000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,73431000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30809000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104240000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50765000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15977000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,643000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15334000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66099000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8000000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58099000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3857000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54242000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54242000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.59
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.59
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34162000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:04:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.59
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,146254000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,146254000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,76776000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,76776000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69478000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15898000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11693000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27591000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,41887000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16056000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,952000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-44000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15148000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26739000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52556000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25817000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5736000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20081000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20081000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34600000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34600000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34358000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:26:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,244476000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,244476000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46489000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46489000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,197987000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72451000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22633000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,122238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,217322000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19335000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49288000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1612000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-47695000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67030000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2400000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64678000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,95517000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30839000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30839000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34700000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34700000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34492000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:15:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-34115000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-34115000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28715000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28715000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-62830000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66030000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12211000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-122238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-43997000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18833000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6572000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2121000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4462000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23295000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2502000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20745000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1532000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22277000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22277000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34394000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34394000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34394000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75804000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75804000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18477000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18477000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57327000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74682000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,92922000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7420000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,175024000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-117697000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6450000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1586000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,340000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4524000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-122221000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-137000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-122084000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-122084000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-122084000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.54
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34500000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.54
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34469000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:44:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.54
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78109000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78109000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24290000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24290000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53819000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77324000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14980000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,77358000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,169662000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-115843000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6330000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1224000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5104000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-120947000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-120000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120827000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120827000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-120827000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.57
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33800000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.57
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33807000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:26:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.57
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,168238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,168238000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21105000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21105000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,147133000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65720000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15330000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,84107000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,165157000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18024000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6419000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1103000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-45000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5361000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23385000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23617000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23617000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23617000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33700000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33700000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33906000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:15:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5600000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5600000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43321000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43321000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-37721000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68874000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16477000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-84107000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,154978000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156222000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-193943000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6510000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,372000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,131000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6007000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-199950000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-199928000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-199928000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-199928000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34030000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.9
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34030000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.9
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34030000.0
AMAG Pharmaceuticals Inc,AMAG,549300HCK1560YVVY867,0000792977,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.9
